These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 21616172)

  • 1. Are propensity scores really superior to standard multivariable analysis?
    Biondi-Zoccai G; Romagnoli E; Agostoni P; Capodanno D; Castagno D; D'Ascenzo F; Sangiorgi G; Modena MG
    Contemp Clin Trials; 2011 Sep; 32(5):731-40. PubMed ID: 21616172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders.
    Arbogast PG; Ray WA
    Am J Epidemiol; 2011 Sep; 174(5):613-20. PubMed ID: 21749976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing treatment effects after adjustment with multivariable Cox proportional hazards regression and propensity score methods.
    Martens EP; de Boer A; Pestman WR; Belitser SV; Stricker BH; Klungel OH
    Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):1-8. PubMed ID: 17960554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study.
    Austin PC; Grootendorst P; Normand SL; Anderson GM
    Stat Med; 2007 Feb; 26(4):754-68. PubMed ID: 16783757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monte Carlo methods in clinical research: applications in multivariable analysis.
    Concato J; Feinstein AR
    J Investig Med; 1997 Aug; 45(6):394-400. PubMed ID: 9291696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneous treatment effects: what does a regression estimate?
    Rhodes W
    Eval Rev; 2010 Aug; 34(4):334-61. PubMed ID: 20647500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic differences in treatment effect estimates between propensity score methods and logistic regression.
    Martens EP; Pestman WR; de Boer A; Belitser SV; Klungel OH
    Int J Epidemiol; 2008 Oct; 37(5):1142-7. PubMed ID: 18453634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addressing the issue of channeling bias in observational studies with propensity scores analysis.
    Lobo FS; Wagner S; Gross CR; Schommer JC
    Res Social Adm Pharm; 2006 Mar; 2(1):143-51. PubMed ID: 17138506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An overview of the objectives of and the approaches to propensity score analyses.
    Heinze G; Jüni P
    Eur Heart J; 2011 Jul; 32(14):1704-8. PubMed ID: 21362706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of confounding bias in non-randomized studies by appropriate weighting.
    Schmoor C; Gall C; Stampf S; Graf E
    Biom J; 2011 Mar; 53(2):369-87. PubMed ID: 21308726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propensity score applied to survival data analysis through proportional hazards models: a Monte Carlo study.
    Gayat E; Resche-Rigon M; Mary JY; Porcher R
    Pharm Stat; 2012; 11(3):222-9. PubMed ID: 22411785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory considerations in the design of comparative observational studies using propensity scores.
    Yue LQ
    J Biopharm Stat; 2012; 22(6):1272-9. PubMed ID: 23075022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to assess intended effects of drug treatment in observational studies are reviewed.
    Klungel OH; Martens EP; Psaty BM; Grobbee DE; Sullivan SD; Stricker BH; Leufkens HG; de Boer A
    J Clin Epidemiol; 2004 Dec; 57(12):1223-31. PubMed ID: 15617947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Propensity scores: an introduction and experimental test.
    Luellen JK; Shadish WR; Clark MH
    Eval Rev; 2005 Dec; 29(6):530-58. PubMed ID: 16244051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxing the rule of ten events per variable in logistic and Cox regression.
    Vittinghoff E; McCulloch CE
    Am J Epidemiol; 2007 Mar; 165(6):710-8. PubMed ID: 17182981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bias reduction in effectiveness analyses of longitudinal ordinal doses with a mixed-effects propensity adjustment.
    Leon AC; Hedeker D; Teres JJ
    Stat Med; 2007 Jan; 26(1):110-23. PubMed ID: 16345035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian propensity score analysis for observational data.
    McCandless LC; Gustafson P; Austin PC
    Stat Med; 2009 Jan; 28(1):94-112. PubMed ID: 19012268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use and misuse of multivariable approaches in interventional cardiology studies on drug-eluting stents: a systematic review.
    D'Ascenzo F; Cavallero E; Biondi-Zoccai G; Moretti C; Omedè P; Bollati M; Castagno D; Modena MG; Gaita F; Sheiban I
    J Interv Cardiol; 2012 Dec; 25(6):611-21. PubMed ID: 22882654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimators and confidence intervals for the marginal odds ratio using logistic regression and propensity score stratification.
    Stampf S; Graf E; Schmoor C; Schumacher M
    Stat Med; 2010 Mar; 29(7-8):760-9. PubMed ID: 20213703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multilevel modelling of clustered grouped survival data using Cox regression model: an application to ART dental restorations.
    Wong MC; Lam KF; Lo EC
    Stat Med; 2006 Feb; 25(3):447-57. PubMed ID: 16143989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.